Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001036050-98-000514
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
12
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 235525
2 AMENDED & RESTATED CERTIFICATE - JULY 10, 1990 EX-3.1(A) 6472
3 AMENDED & RESTATED CERTIFICATE - JUNE 20, 1996 EX-3.1(B) 2754
4 AMENDED & RESTATED CERTIFICATE - JUNE 20, 1996 EX-3.1(C) 2709
5 CERTIFICATE OF CHANGE OF REGISTERED AGENT EX-3.1(D) 1614
6 COPY OF COMPANY'S BY-LAWS, DATED MARCH 27, 1995 EX-3.2 34478
7 WARRANT, DECEMBER 31, 1997, ISSUED BY INNOVIR EX-10.34 19241
8 FUTURE EQUITY PURCHASES BETWEEN VIMRX AND INNOVIR EX-10.35 10326
9 LIST OF SUBSIDIARIES EX-21 779
10 CONSENT OF INDEPENDENT AUDITORS 03/30/98 EX-23.A 814
11 INDEPENDENT AUDITORS' CONSENT EX-23.B 799
12 FINANCIAL DATA SCHEDULE EX-27 4034
  Complete submission text file 0001036050-98-000514.txt   322330
Mailing Address 2751 CENTERVILLE RD, STE 210 LITTLE FALL II WILMINGTON DE 19808
Business Address 2751 CENTERVILLE RD, STE 210 LITTLE FALL II WILMINGTON DE 19808 3029981734
VIMRX PHARMACEUTICALS INC (Filer) CIK: 0000864009 (see all company filings)

EIN.: 061192468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28124 | Film No.: 98582576
SIC: 2834 Pharmaceutical Preparations